Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025 or the MIRACLE Medical Technology Act of 2025This bill requires the Department of Health and Human Services (HHS) to implement a program for the United States and Israel to collaborate on developing and delivering health care products and services. The program must include coordinated activities in specified areas, including research and development, use of innovative technology, intellectual property protection, regulatory harmonization, disease prevention, and biological product manufacturing. The bill authorizes HHS to establish a joint United States-Israel Health Care Collaboration Center in the United States to leverage existing expertise for advancing the program’s purposes.

Restoring Trade Fairness ActThis bill establishes various trade measures related to China, including by revoking China's permanent normal trade relations (PNTR) status and increasing the rates of duty (i.e., tariffs) on Chinese imported goods. The bill prohibits imported goods originating from North Korea, China, Russia, or Iran from receiving de minimis treatment. (Current law allows for U.S. imports under a de minimis threshold of $800 per shipment to enter free of tariffs, fees, and taxes.)Specifically, the bill revokes China's PNTR status. Currently, China's PNTR status allows for Chinese goods to have duty rates set forth in column 1 of the Harmonized Tariff Schedule of the United States (HTS). With the removal of China's PNTR status, the bill generally sets the applicable duty rates on imported Chinese goods at the higher rates listed in column 2 of the HTS, with exceptions.The bill establishes a minimum duty rate of 35% for all Chinese goods, which requires column 2 rates to be at least 35%. However, the bill establishes a minimum duty rate of 100% for a list of specified goods (e.g., various minerals, certain vaccines and drugs, and certain defense-related articles). Duty rates are phased in over five years and adjusted annually for inflation.The bill alsoauthorizes the President to take additional actions related to trade with China, requires merchandise imported from China to be appraised based on U.S. value, and establishes a trust fund to compensate U.S. producers for lost revenue resulting from retaliatory actions by China.

Prompt Approval of Safe Generic Drugs ActThis bill authorizes the Food and Drug Administration (FDA) to approve certain applications to market a generic drug despite the omission of certain safety information from the generic drug's labeling.Specifically, the FDA may not deem an abbreviated application for approval of a generic drug ineligible for approval solely because the drug's labeling omits safety information that is protected under another drug's patent or exclusivity protections. Similarly, a drug that is approved under this bill may not be considered mislabeled for lacking such safety information.Generally, an abbreviated application, for the purposes of this bill, is one that (1) uses required information from studies not conducted by the applicant; or (2) seeks approval of a drug that is, for drug approval purposes, a duplicate of an already-approved drug (i.e., a generic drug). Currently, the labeling for such a generic drug must generally be identical to that of the already-approved drug. This bill provides an exception to that requirement under the specified circumstances. For any drug approved under this bill, the FDA must require the drug's labeling to include any safety information that is necessary to assure safe use.

Working Families Housing Tax Credit Act

Stop Sports Blackouts Act of 2025This bill requires cable and satellite broadcast providers to issue rebates to customers who are denied access to video programming included in their subscription because of programming negotiations. Specifically, where a provider’s negotiations related to the retransmission or carriage of video programming result in the provider failing to offer access to programming included in a customer’s subscription, the customer must be issued a rebate for the affected period. The Federal Communications Commission is directed to issue rules to this effect, including to establish the appropriate amount for such a rebate.  

Aviation Noise and Emissions Mitigation Act

Defending Domestic Orange Juice Production Act of 2025

This joint resolution nullifies the Environmental Protection Agency (EPA) rule titled Waste Emissions Charge for Petroleum and Natural Gas Systems: Procedures for Facilitating Compliance, Including Netting and Exemptions and published on November 18, 2024. The rule outlines compliance requirements under the Methane Emissions Reduction Program. Under the program, the EPA collects an annual charge on emissions of methane and other greenhouse gases from the oil and gas sector if the emissions exceed specified waste emissions thresholds.

Stop the Censorship Act

Setting Consumer Standards for Lithium-Ion Batteries Act

ORPHAN Cures Act Optimizing Research Progress Hope And New Cures Act

Banning SPR Oil Exports to Foreign Adversaries Act Banning Strategic Petroleum Reserve Oil Exports to Foreign Adversaries Act

Train More Primary Care Doctors Act of 2025

This joint resolution nullifies the Environmental Protection Agency rule titled Trichloroethylene (TCE); Regulation Under the Toxic Substances Control Act (TSCA) (89 Fed. Reg. 102568) and published on December 17, 2024. Among other elements, the rule prohibits the manufacturing, import, processing, and distribution in commerce of trichloroethylene (TCE) for all uses (including consumer uses), and prohibits the industrial and commercial use of TCE.

Expressing support for the designation of February 4, 2025, as "National Cancer Prevention Day".